AR040131A1 - Anticonceptivo auto-administrado - Google Patents

Anticonceptivo auto-administrado

Info

Publication number
AR040131A1
AR040131A1 ARP030101860A ARP030101860A AR040131A1 AR 040131 A1 AR040131 A1 AR 040131A1 AR P030101860 A ARP030101860 A AR P030101860A AR P030101860 A ARP030101860 A AR P030101860A AR 040131 A1 AR040131 A1 AR 040131A1
Authority
AR
Argentina
Prior art keywords
long
acting
contraceptive
ester
effective amount
Prior art date
Application number
ARP030101860A
Other languages
English (en)
Spanish (es)
Inventor
Nijs Henrik De
Der Voort Hendrikus Adrianus Antonius Van
Dirk Leysen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AR040131A1 publication Critical patent/AR040131A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
ARP030101860A 2002-05-30 2003-05-28 Anticonceptivo auto-administrado AR040131A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02077126 2002-05-30

Publications (1)

Publication Number Publication Date
AR040131A1 true AR040131A1 (es) 2005-03-16

Family

ID=29595016

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101860A AR040131A1 (es) 2002-05-30 2003-05-28 Anticonceptivo auto-administrado

Country Status (23)

Country Link
US (1) US20060094698A1 (enExample)
EP (1) EP1513587A1 (enExample)
JP (1) JP2005533036A (enExample)
KR (1) KR20050010014A (enExample)
CN (1) CN1298330C (enExample)
AR (1) AR040131A1 (enExample)
AU (1) AU2003238084A1 (enExample)
BR (1) BR0311423A (enExample)
CA (1) CA2487639A1 (enExample)
HR (1) HRP20041126A2 (enExample)
IL (1) IL165204A0 (enExample)
IS (1) IS7539A (enExample)
MX (1) MXPA04011928A (enExample)
NO (1) NO20044976L (enExample)
NZ (1) NZ536735A (enExample)
PE (1) PE20040676A1 (enExample)
PL (1) PL373074A1 (enExample)
RS (1) RS100904A (enExample)
RU (1) RU2328289C2 (enExample)
TW (1) TW200404552A (enExample)
UA (1) UA80822C2 (enExample)
WO (1) WO2003101539A1 (enExample)
ZA (1) ZA200409646B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
KR20150011346A (ko) 2012-04-06 2015-01-30 안타레스 팔마, 인코퍼레이티드 테스토스테론 조성물의 바늘-보조식 젯 주입 투여 장치 및 방법
WO2014093818A2 (en) * 2012-12-14 2014-06-19 Bioject, Inc. Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
DK2953667T3 (da) * 2013-02-11 2020-01-27 Antares Pharma Inc Nålestøttet jetinjektionsindretning med reduceret udløserkraft
WO2015023557A1 (en) 2013-08-12 2015-02-19 Nanomedical Systems, Inc. Device and method for sustained release of low water solubility therapeutic agent in solubilizer
CN114026106B (zh) * 2019-03-06 2025-01-21 普洛拉治疗公司 阿比特龙前药
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2970153A (en) * 1959-07-27 1961-01-31 Leo Ab Alkoxyphenyl-propionyl esters of 17alpha-hydroxyprogesterone
DE3836862A1 (de) * 1988-10-27 1990-05-03 Schering Ag Mittel zur transdermalen applikation von steroidhormonen
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
CN1135716A (zh) * 1993-12-27 1996-11-13 阿克佐诺贝尔公司 经皮吸收的药用制剂
US5599302A (en) * 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
WO1997003709A1 (de) * 1995-07-17 1997-02-06 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel
TR200003743T2 (tr) * 1998-06-19 2001-07-23 Akzo Nobel N.V. Testosteron türevi.
WO1999067270A1 (en) * 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
RU2002124602A (ru) * 2000-02-15 2004-03-10 Шеринг Акциенгезелльшафт (De) Композиция для мужской контрацепции, включающая норэтистерон
MXPA03001147A (es) * 2000-08-23 2003-10-06 Akzo Nobel Nv Nueva formulacion de ester de testosterona para uso humano.

Also Published As

Publication number Publication date
RU2328289C2 (ru) 2008-07-10
CN1655847A (zh) 2005-08-17
PE20040676A1 (es) 2004-09-25
IS7539A (is) 2004-11-18
BR0311423A (pt) 2005-03-15
CN1298330C (zh) 2007-02-07
MXPA04011928A (es) 2005-03-31
IL165204A0 (en) 2005-12-18
US20060094698A1 (en) 2006-05-04
TW200404552A (en) 2004-04-01
KR20050010014A (ko) 2005-01-26
EP1513587A1 (en) 2005-03-16
UA80822C2 (en) 2007-11-12
CA2487639A1 (en) 2003-12-11
RU2004138811A (ru) 2005-06-10
AU2003238084A1 (en) 2003-12-19
HRP20041126A2 (en) 2005-04-30
NO20044976L (no) 2004-12-23
JP2005533036A (ja) 2005-11-04
WO2003101539A1 (en) 2003-12-11
RS100904A (sr) 2006-10-27
NZ536735A (en) 2007-01-26
ZA200409646B (en) 2006-06-28
PL373074A1 (en) 2005-08-08

Similar Documents

Publication Publication Date Title
BR0012515A (pt) Seringa sem agulha funcionando com um gerador de onda de choque através de uma parede
IS2646B (is) Nálarlaus sprauta með samþjappað form
AR037305A1 (es) Autoinyector neumatico energizado
ATE239518T1 (de) Vorgefüllte injektionsampullen mit zurückziehbarer nadel
CA2142901A1 (en) Medication injection device
AR026986A1 (es) Implante farmaceutico con contenido de componentes de liberacion inmediata y liberacion sostenida y metodos de administracion
AR065579A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
DK2926847T3 (da) Implanterbar infusionsapparat med fremførbar og tilbagetrækkelig nål
BR0208064A (pt) dispositivo médico, e, processo para injetar medicamento
WO2003047663A3 (en) Automatic injector
AR083348A1 (es) Auto-inyector
PT1278565E (pt) Seringa sem agulha que funciona com uma carga pirotecnica bicomposta
EA200400820A1 (ru) Усовершенствования устройства для впрыскивания лекарств
BR0111863A (pt) Seringa sem agulha munida de um reservatório modulável
MX2022012353A (es) Metodos para el inicio de la dosis de los tratamientos con aripiprazol.
NO20044976L (no) Befruktningshindrende middel av en oljeholdig losning for selv-administrering
WO2007084650A3 (en) Single-dose needle-free administration of antithrombotic medications
ATE366595T1 (de) System zur verabreichung eines injizierbaren produkts
JP2005533036A5 (enExample)
AR062894A1 (es) Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths)
ECSP045462A (es) Inyección anticonceptiva auto-administrada de solución aceitosa
CN201290970Y (zh) 一种自毁式注射器
RU2008121304A (ru) Способ лечебной блокады при синдроме ягодичной мышцы
CN201290966Y (zh) 一种自毁式注射器
CN2915136Y (zh) 医用自毁型注射器

Legal Events

Date Code Title Description
FB Suspension of granting procedure